Latest Equity Raise News

Challenger Gold has completed a Pre-Feasibility Study for toll milling at its Hualilan Gold Project, revealing strong economics, low capital requirements, and a swift payback period. The study underscores the project's potential to generate significant cash flow over three years through a toll milling arrangement with Austral Gold.

Babylon Pump & Power Limited (ASX – BPP) announces transformational acquisitions of Blue Hire and Matrix Hydro Services, significantly expanding its equipment rental and water management capabilities. The company is funding this growth through a $3.5 million entitlement offer and a $21.2 million debt facility, targeting a doubling of EBITDA by FY26.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.

Cann Group Limited has reported a strong operational update, exceeding its medicinal cannabis production targets and significantly reducing costs, while expanding sales channels and securing fresh capital to bolster its balance sheet.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.

Agrimin Limited has successfully raised $2.5 million through an oversubscribed equity placement to fund the strategic review of its Mackay Potash Project and explore new mineral opportunities.

American West Metals has successfully raised A$5.9 million as part of a broader A$14.4 million funding package to advance its Storm Copper Project in Canada, aiming to fast-track exploration and development activities.

ALS Limited has announced a fully underwritten A$350 million equity placement to fund major upgrades to its global laboratory network and support future growth initiatives, aiming for mid single-digit EPS accretion by FY25 pro forma.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.

Metro Performance Glass reported a net loss for FY25 amid market softness but outlines a clear recovery plan with leadership changes and an equity raise to strengthen its position.